HOME > BUSINESS > Article

Text Size

small

medium

large


Mitsubishi Tanabe Unit Launches Clinical Trials for COVID-19 Vaccine

Mitsubishi Tanabe Unit Launches Clinical Trials for COVID-19 Vaccine

   Osaka, July 15 (Jiji Press)--Japan's Mitsubishi Tanabe Pharma Corp. said Wednesday that Phase 1 clinical trials have started in Canada to ensure the safety of a COVID-19 vaccine candidate developed by its Quebec-based Medicago Inc. unit.
   A total of 180 healthy subjects will get two doses of candidate vaccines, administered 21 days apart.

To read a full story, please click here to find out how to subscribe.

BUSINESS

Aomori Tourism Information

HEADLINES

POLITICS
Japan Cautious about Importing Russia's Coronavirus Vaccine: Health Min. Kato
ECONOMY
Japan Govt Approves 1st Batch of Cultural Tourism Programs Involving 10 Areas
SPORTS
J. League Soccer: Up to Sagan Tosu Players, Staff Members May Have Coronavirus
OTHER
6,664 People Ambulanced for Heat Stroke across Japan in Week through Sun.

AFP-JIJI PRESS NEWS JOURNAL


Photos